(−)-Epigallocatechin-3-gallate derivatives combined with cisplatin exhibit synergistic inhibitory effects on non-small-cell lung cancer cells

BACKGROUND: Non-small-cell lung cancer (NSCLC) is the leading cause of cancer-related death worldwide. The inhibition of epidermal growth factor receptor (EGFR) signaling by tyrosine kinase inhibitors or monoclonal antibodies plays a key role in NSCLC treatment. Unfortunately, these treatment strate...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jing, Sun, Peiyuan, Wang, Qi, Zhang, Pan, Wang, Yuna, Zi, Chengting, Wang, Xuanjun, Sheng, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791019/
https://www.ncbi.nlm.nih.gov/pubmed/31636509
http://dx.doi.org/10.1186/s12935-019-0981-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791019/
https://www.ncbi.nlm.nih.gov/pubmed/31636509
http://dx.doi.org/10.1186/s12935-019-0981-0

Ejemplares similares